LDL Cholesterol Clinical Trial
Official title:
Randomized, Double-Blind, Placebo-Controlled, Phase 2, Dose Finding Study to Evaluate the Efficacy and Safety of LIB003 in Patients on Stable Lipid-Lowering Therapy Requiring Additional LDL-C Reduction
Study to assess the LDL-C lowering efficacy of different doses of LIB003 administered every 4 weeks in subjects on stable statin and/or ezetimibe therapy
Randomized, Double-Blind, Placebo-Controlled, Phase 2 study to assess the LDL-C lowering efficacy at Week 12 of various doses of LIB003 administered subcutaneously (SC) every 4 weeks (Q4W) in patients with hypercholesterolemia on stable diet and oral LDL-C-lowering drug therapy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01028274 -
Safety and Efficacy of a Natural Health Product in Reducing Cholesterol and Triglyceride Levels.
|
Phase 1/Phase 2 | |
| Completed |
NCT00233649 -
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
|
Phase 4 | |
| Recruiting |
NCT05765370 -
LDL Cholesterol TARGETs in OLDer Patients (Ageā„75 Years) With ASCVD (TARGET OLD)
|
N/A | |
| Recruiting |
NCT05778656 -
Cardiovascular Risk Prevention With a Mediterranean Dietary Pattern Reduced in Saturated Fat
|
N/A | |
| Completed |
NCT01859455 -
Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins
|
Phase 1 | |
| Active, not recruiting |
NCT02068248 -
Effect of Viscous Soluble Fibers on Serum Cholesterol Levels
|
N/A | |
| Completed |
NCT03346486 -
Dietary Intervention With Brain-friendly Diet
|
N/A | |
| Completed |
NCT02330406 -
Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial
|
Phase 4 | |
| Completed |
NCT00522158 -
Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition
|
Phase 4 |